tiprankstipranks
Citius Oncology (CTOR)
NASDAQ:CTOR
US Market
Holding CTOR?
Track your performance easily

Citius Oncology (CTOR) Technical Analysis

45 Followers

Technical Sentiment

Overall Consensus
Strong Sell
5Bullish
1Neutral
16Bearish
Technical Analysis Consensus
Neutral
5Bullish
1Neutral
4Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Citius Oncology’s (CTOR) Moving Averages Convergence Divergence (MACD) indicator is -0.16, suggesting Citius Oncology is a Sell.
Citius Oncology’s (CTOR) 20-Day exponential moving average is 1.09, while Citius Oncology’s (CTOR) share price is $0.912, making it a Sell.
Citius Oncology’s (CTOR) 50-Day exponential moving average is 2.04, while Citius Oncology’s (CTOR) share price is $0.912, making it a Sell.

Citius Oncology (CTOR) Pivot Points

Nov 26, 2024, 08:09 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.64
0.75
0.80
0.90
0.95
1.06
1.11
Fibonacci
0.75
0.81
0.84
0.90
0.96
1.00
1.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Citius Oncology (CTOR) Moving Averages

Nov 26, 2024, 08:09 PM
Period
Simple
Exponential
MA5
0.93Sell
0.92Sell
MA10
1.03Sell
1.00Sell
MA20
1.11Sell
1.09Sell
MA50
1.22Sell
2.04Sell
MA100
5.71Sell
4.30Sell
MA200
8.44Sell
7.04Sell
Citius Oncology’s (CTOR) 10-Day exponential moving average is 1.00, while Citius Oncology’s (CTOR) share price is $0.912, making it a Sell.
Citius Oncology’s (CTOR) 100-Day exponential moving average is 4.30, while Citius Oncology’s (CTOR) share price is $0.912, making it a Sell.
Citius Oncology’s (CTOR) stock price is $0.912 and Citius Oncology’s (CTOR) 50-day simple moving average is 1.22, creating a Sell signal.
Citius Oncology’s (CTOR) stock price is $0.912 and Citius Oncology’s (CTOR) 100-day simple moving average is 5.71, creating a Sell signal.
Citius Oncology’s (CTOR) stock price is $0.912 and Citius Oncology’s (CTOR) 200-day simple moving average is 8.44, creating a Sell signal.

Citius Oncology (CTOR) Technical Indicators

Nov 26, 2024, 08:09 PM
Name
Value
Implied Action
RSI (14)
31.89
Neutral
STOCH (9,6)
1.90
Buy
STOCHRSI (14)
1.90
Buy
MACD (12,26)
-0.16
Sell
ADX (14)
12.12
Buy
Williams %R
-100.00
Buy
CCI (14)
-147.17
Buy
ATR (14)
0.17
-
Ultimate Oscillator
22.64
Sell
ROC
-28.57
Sell
Citius Oncology’s (CTOR) Relative Strength Index (RSI) is 31.89, creating a Neutral signal.
Citius Oncology’s (CTOR) Trend Strength Indicator (ADX) is 12.12, creating a Buy signal.
Citius Oncology’s (CTOR) Commodity Channel Index (CCI) is -147.17, creating a Buy signal.
Citius Oncology’s (CTOR) Price Rate of Change (ROC) is -28.57, creating a Sell signal.

FAQ

Is CTOR a Buy, Hold, or Sell?
Based on CTOR’s technical indicators, CTOR is a Strong Sell.
    What is CTOR’s RSI (14)?
    CTOR’s RSI (14) is 31.89, which suggests CTOR is a Neutral.
      What is CTOR’s MACD?
      CTOR’s MACD is -0.16, which suggests CTOR is a Sell.
        What is CTOR’s 5-day moving average?
        CTOR’s 5-day moving average is 0.93, which suggests CTOR is a Sell.
          What is CTOR’s 20-day moving average?
          CTOR 20-day moving average is 1.11, which suggests CTOR is a Sell.
            What is CTOR’s 50-day moving average?
            CTOR’s 50-day moving average is 1.22, which suggests CTOR is a Sell.
              What is CTOR’s 200-day moving average?
              CTOR’s 200-day moving average is 8.44, which suggests CTOR is a Sell.
                What is CTOR’s Williams % R (14)?
                CTOR’s Williams % R (14) is -100.00, which suggests CTOR is a Buy.
                  What is CTOR’s CCI (14)?
                  CTOR’s CCI (14) is -147.17, which suggests CTOR is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis